Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746051 · ClinicalTrials.gov registry record
A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants
A clinical trial of RSV Infections, sponsored by Shionogi.
- Completed
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT06746051: Completed study of RSV Infections, sponsored by Shionogi.
NCT06746051 is a study of RSV Infections that has completed, run by Shionogi. The registered enrollment target is 100 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06746051, a study of RSV Infections, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of this study is to observe how viral load and titer change over time in participants with RSV and how data from hospitalized participants compares with data from non-hospitalized participants.
Primary Outcome
Viral load will be reported from results of quantitative reverse-transcription polymerase chain reaction (qRT-PCR).
Conditions Studied
Study Locations (2)
New York
- SUNY Upstate Medical University - Syracuse
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-09 |
| Est. Completion | 2025-03-31 |
What the finished NCT06746051 record still lists
NCT06746051 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with RSV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT06746051 reports a single indexed study location in New York, Washington.
Frequently Asked Questions
What is clinical trial NCT06746051 about?
NCT06746051 is a clinical study titled "A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants". The primary purpose of this study is to observe how viral load and titer change over time in participants with RSV and how data from hospitalized participants compares with data from non-hospitalized participants.
What is the current status of trial NCT06746051?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2024-12-09. Estimated completion is 2025-03-31.
What conditions does trial NCT06746051 study?
This clinical trial studies the following conditions: RSV Infections.
Who is sponsoring clinical trial NCT06746051?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06746051 being conducted?
This trial has 2 study locations across New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI